Latest News

: Moderna to invest $500 million in ‘state-of-the-art’ mRNA vaccine factory in Africa

Moderna, the biotechnology company behind a key COVID-19 vaccine, says it will build a new facility in Africa, aimed at producing up to 500 million doses of vaccines a year.

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News